Pregnant women should be treated only if the expected benefit outweighs the possible risks to the pregnant women and foetus. Caution should be exercised when this product is administered to a nursing woman. Piperacillin is excreted in low concentrations in human milk. Tazobactam concentrations in human milk have not been studied.